- Home
- DSWL vs BTAI Comparison
DSWL vs BTAI Comparison
Compare DSWL & BTAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DSWL | BTAI |
|---|---|---|
| Founded | 1987 | 2017 |
| Country | Macau | United States |
| Employees | N/A | N/A |
| Industry | Plastic Products | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 56.7M | 36.5M |
| IPO Year | 2000 | 2018 |
Fundamental Metrics
Financial Performance| Metric | DSWL | BTAI |
|---|---|---|
| Price | $3.50 | $1.65 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $26.67 |
| AVG Volume (30 Days) | 9.9K | ★ 301.9K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 5.56% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $261.81 |
| P/E Ratio | $4.59 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.03 | $1.17 |
| 52 Week High | $4.48 | $8.08 |
Technical Indicators
Market Signals| Indicator | DSWL | BTAI |
|---|---|---|
| Relative Strength Index (RSI) | 46.50 | 49.74 |
| Support Level | $3.27 | $1.50 |
| Resistance Level | $3.68 | $1.72 |
| Average True Range (ATR) | 0.14 | 0.11 |
| MACD | -0.01 | 0.02 |
| Stochastic Oscillator | 37.97 | 49.06 |
Price Performance
Historical ComparisonAbout DSWL Deswell Industries Inc.
Deswell Industries Inc is engaged in the manufacturing and selling of injection-molded plastic parts and components. In addition, it also offers manufacturing services for electronic products and subassemblies and manufactures metallic molds and accessory parts for original equipment manufacturers and contract manufacturers. The company conducts all of its manufacturing activities at separate plastics, electronics and metallic operation factories located in the People's Republic of China. It operates through the Plastic Injection Molding and Electronic Products Assembling segments. The firm offers products such as automobile components, medical testing equipment, parts for audio equipment, av receivers, active subwoofers, digital system key sets, communication products and others.
About BTAI BioXcel Therapeutics Inc.
BioXcel Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on drug development utilizing novel artificial intelligence (AI) to identify the next wave of medicines across neuroscience and immuno-oncology. The pipeline products of the company are BXCL501 and BXCL701. The company's commercial product, IGALMI (developed as BXCL501) is a proprietary, sublingual film formulation of dexmedetomidine approved by the FDA for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder in adults.